September 26th 2023
A trio of healthcare providers offer perspective on educating patients regarding biosimilar and interchangeability.
September 26th 2023
September 12th 2023
September 12th 2023
September 10th 2023
Acute Myeloid Leukemia: Novel Targeted Therapies and the Role of the Pharmacist
0.75 Credit / Oncology
View More
The Role of Immune Checkpoint Inhibitors in Cutaneous Melanoma: Evaluating Therapeutic Trends
0.75 Credit / Oncology
View More
Recognizing Rett Syndrome: Managed Care Insights on Disease Burden
1.5 Credits / Neurology, Rare Diseases
View More
CAR T-Cell Therapy Advances in Lymphoma: Implications for Managed Care
1.5 Credits / Hematology, Oncology
View More
HIV Therapy: Addressing Unanswered Questions to Optimize Care
2.5 Credits / HIV/AIDS
View More
The Current Landscape of Ending the HIV Epidemic: A Focus on PrEP
1.0 Credit / HIV/AIDS, Infectious Diseases
View More
Over-the-Counter Treatment Paradigms for Pain Management: Adapting to the “New Normal” (Technician Credit)
1 Credit / Pain Management/Opioids
View More
Community Practice Connections™: Controversies and Conversations About HER2- Expressing Breast Cancer…Advances in Management of HER2-Low to -Positive Disease
View More
Study Highlights Parental Motivations, Expectations for Children with Gastroenteritis
September 26th 2023Participants indicated multiple factors affected their decision to contact out-of-hours primary care for their child with gastroenteritis and detailed areas of disconnect between their expectations and actions taken by the general practitioner.
‘Clearing Up Seb Derm’ Launched to Enhance Awareness of Seborrheic Dermatitis for Diverse Skin Types
The new educational initiative was launched to provide useful insights from dermatologists as well as personal accounts by patients with seborrheic dermatitis with many different backgrounds.
Earlier bDMARD Initiation Can Prevent Long-Term Adverse Events in Juvenile Arthritis
September 25th 2023A study on juvenile idiopathic arthritis emphasizes early initiation of biologic treatment for better long-term outcomes, as delayed treatment is linked to greater physical disability and worse quality of life in adulthood.
Tirzepatide Bests Semaglutide For A1c, Weight Loss in Indirect Comparison of Clinical Trial Data
September 25th 2023A network meta-analysis suggests tirzepatide may be more effective than semaglutide in reducing HbA1c and body weight in type 2 diabetes but may increase gastrointestinal adverse events, especially at higher doses.
How Did Canadian Wildfires Impact Emergency Department Visits for Asthma Syndrome in New York?
New research on the effects of the Canadian wildfires on asthma syndrome in patients sheds light on the downstream effects of ecological disaster on regions outside of those affected.